FDA approval gained, Glaxo awaits key committee blessing for ShingrixThe FDA granted approval to GSK’s new shingles vaccine Shingrix on Friday, giving the company the green light Share XFDA approval gained, Glaxo awaits key committee blessing for Shingrixhttps://pharmaphorum.com/news/shingrix-approved-glaxo-awaits-cdc-decision/
Tipped to hit $1bn, GSK’s Shingrix gains committee approvalGlaxoSmithKline’s shingles vaccine Shingrix has gained the unanimous backing of an FDA advisory committee. The Vaccines and Related Share XTipped to hit $1bn, GSK’s Shingrix gains committee approvalhttps://pharmaphorum.com/news/tipped-hit-1bn-gsks-shingrix-gains-committee-approval/
